Global Digital Genome Market Growth (Status and Outlook) 2023-2029

Global Digital Genome Market Growth (Status and Outlook) 2023-2029

Personal genomics is the branch of science giving insight into human metabolism and disease strains based on individual genetic traits with familial genetics playing a contributory role. Segmentation of digital genome market by Component Type comprises hardware, software and services. Digital genomics is an extension to personal genomics banking on intensive study data collated by research and co-relating this factual representation with published literature.

LPI (LP Information)' newest research report, the “Digital Genome Industry Forecast” looks at past sales and reviews total world Digital Genome sales in 2022, providing a comprehensive analysis by region and market sector of projected Digital Genome sales for 2023 through 2029. With Digital Genome sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Genome industry.

This Insight Report provides a comprehensive analysis of the global Digital Genome landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Digital Genome portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Digital Genome market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Genome and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Genome.

The global Digital Genome market size is projected to grow from US$ 6811.9 million in 2022 to US$ 10540 million in 2029; it is expected to grow at a CAGR of 6.4% from 2023 to 2029.

The global digital genome market is driven by increase in chronic diseases, global rise in geriatric population, demand for accuracy in diagnosis and treatment of diseases using digital genome techniques and applications, increased research in genomics, and rise in funding related to digitalization. On February 8, 2016, the National Human Genome Research Institute proposed its novel initiative named Genes, Environment, and Health Initiative (GEI). The aim of this project is to assist the research and development related to better understanding of the genetic contribution and their role in the development of diseases. Funding by government agencies is one of the major drivers of the global digital genome market. For example, the Genomics R&D Initiative (GRDI) based in Canada cooperates with other federal science departments and agencies in the development of genomic research. On the other hand, high costs related with the use of digital genome techniques and products, less awareness about digital genome in developing economies, and side effects related to use of new product are factors anticipated to hamper market growth.

This report presents a comprehensive overview, market shares, and growth opportunities of Digital Genome market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Sequencing Services
Sequencing Instruments
Sequencing Consumables
Bioinformatics
Sample Preparation Kits and Reagents

Segmentation by application
Diagnostics
Agriculture & Animal Research
Personalized Medicine
Drug Discovery
Treatment Analysis

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Umbel
NanoString
BiogeniQ
GenomeMe
Illumina

Please note: The report will take approximately 2 business days to prepare and deliver.